Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
Providing evidence for a new online MS assessment tool, researchers discovered the overlooked subtype in patients of all ages ...
For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...
The MIND diet significantly reduces disability and fatigue, improving quality of life for people with MS, a long-term study ...
Higher intake of ultra-processed foods (UPFs) may exacerbate disease activity in early multiple sclerosis (MS), according to ...
People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...
7hon MSN
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...
Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.
Major revisions to the diagnostic criteria for neuromyelitis optica spectrum disorder will broaden their scope to related syndromes and have a substantial clinical impact.
Harlow is a Great Dane, which is uncommon for a service dog, but Hall is also tall at 6 feet 3 inches. After spending 15 ...
A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results